Allevyn AG Adhesive Silver Barrier Dressing

How to use Allevyn AG Barrier Dressing?

Step 1:

• Select an appropriate size dressing 
• Prepare and clean the skin around the wound 
• Skin prep protective wipes may be used to protect fragile skin 
• Peel back the protector papers and anchor the dressing over the wound 
• Smooth the dressing into place, ensuring that the edges of the dressing are not wrinkled

Step 2

• During the early stages of treatment, dressings should be inspected frequently; dressings can be left in place until exudate can be seen through the outer waterproof film layer and approaches 3/4" from the edge of the dressing

Step 3

• To remove, lift one corner of the dressing and lift it gently away from the wound

Precautions:

• For external use only
• It is not compatible with oxidizing agents or hydrogen peroxide, as these can break down the absorbent polyurethane component of the dressing
• Dressings are not intended to provide treatment for infected wounds
• Allevyn dressing may be used on infected wounds being managed in accordance with institutional clinical protocols for infection abatement as an adjunct to the standard treatment regimen to provide a barrier to bacterial penetration
• May not be compatible with topical antimicrobials
• In common with all adhesive products, some cases of irritation and/or maceration of the skin surrounding the wound may be observed
• It should be noted that inappropriate use or too frequent dressing changes, particularly on patients with fragile skin may result in skin stripping
• Avoid contact with electrodes or conductive gels during electronic measurements e.g. EEG and ECG
• When used on a patient during MRI (Magnetic Resonance Imaging) examination some warming may be experienced
• Allevyn adhesive foam dressing is not compatible with oil-based products such as petrolatum
• Not suitable for use on cavity wounds but may be used over cavity wounds as a secondary dressing
• As with all products containing silver sulfadiazine the following precautions should be noted, especially when covering a large surface area with the dressing
• Use caution in patients with significant hepatic or renal impairment
• Use caution in individuals known to have glucose-6-phosphate dehydrogenase deficiency
• Effects of systemically administered drugs may be altered
• This can especially apply to oral hypoglycaemic agents and to phenytoin
• In the case of these drugs, it is recommended that blood levels should be monitored as their effect can be potentiated

Customer Reviews